Universe Pharmaceuticals Inc (UPC)
2.19
-0.07
(-3.10%)
USD |
NASDAQ |
May 02, 16:00
2.10
-0.09
(-4.11%)
After-Hours: 19:12
Universe Pharmaceuticals EPS Diluted (TTM): -1.70 for Sept. 30, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.70 |
| March 31, 2023 | -3.09 |
| September 30, 2022 | -2.41 |
| March 31, 2022 | 1.42 |
| September 30, 2021 | 3.58 |
| Date | Value |
|---|---|
| March 31, 2021 | 3.350 |
| September 30, 2020 | 2.160 |
| March 31, 2020 | 2.443 |
| September 30, 2019 | 2.158 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-3.09
Minimum
Mar 2023
3.58
Maximum
Sep 2021
0.8788
Average
2.158
Median
Sep 2019
EPS Diluted (TTM) Benchmarks
| Akso Health Group | -0.24 |
| Sinovac Biotech Ltd | -1.06 |
| CASI Pharmaceuticals Inc | -2.03 |
| Zai Lab Ltd | -3.50 |
| I-MAB | -3.806 |